• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines Aminotriazines N-aliphatic s-triazines

SEBUTHYLAZINE-DESETHYL-2-HYDROXY (CAS No. 33124-63-9): A Comprehensive Overview

Compound SEBUTHYLAZINE-DESETHYL-2-HYDROXY (CAS No. 33124-63-9) is a significant derivative in the field of pharmaceutical chemistry, exhibiting unique properties that make it valuable for various research applications. This compound has garnered attention due to its structural complexity and potential biological activities, which have been extensively studied in recent years.

The chemical structure of SEBUTHYLAZINE-DESETHYL-2-HYDROXY features a benzylamine moiety linked to a pyridine ring, with a hydroxyl group at the 2-position. This configuration imparts specific interactions with biological targets, making it a promising candidate for drug discovery and development. The presence of the hydroxyl group enhances its solubility and reactivity, which are critical factors in medicinal chemistry.

In recent years, the pharmaceutical industry has seen a surge in interest for compounds that modulate neurotransmitter systems. SEBUTHYLAZINE-DESETHYL-2-HYDROXY has been investigated for its potential role in affecting serotonin and dopamine pathways, which are implicated in various neurological disorders. Preliminary studies suggest that this compound may have neuroprotective properties, making it a candidate for further exploration in treating conditions such as depression and Parkinson's disease.

The synthesis of SEBUTHYLAZINE-DESETHYL-2-HYDROXY involves multi-step organic reactions, including alkylation, hydroxylation, and cyclization processes. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets stringent quality standards. These methodologies often incorporate green chemistry principles to minimize environmental impact while maintaining high efficiency.

One of the most compelling aspects of SEBUTHYLAZINE-DESETHYL-2-HYDROXY is its potential as a scaffold for drug design. Researchers have leveraged its structural features to develop analogs with enhanced pharmacological profiles. For instance, modifications at the benzylamine moiety have been shown to improve binding affinity to specific receptors, while alterations at the pyridine ring can modulate metabolic stability.

The pharmacokinetic properties of SEBUTHYLAZINE-DESETHYL-2-HYDROXY have also been thoroughly examined. Studies indicate that it exhibits moderate oral bioavailability and a favorable half-life, suggesting its potential for therapeutic use. Additionally, its metabolic pathways have been mapped out, providing insights into how it is processed within the body. This information is crucial for optimizing dosing regimens and minimizing side effects.

In vitro studies have demonstrated the compound's ability to interact with various enzymes and receptors relevant to neurological function. For example, it has shown inhibitory effects on monoamine oxidase (MAO) enzymes, which are involved in the breakdown of neurotransmitters like serotonin and dopamine. Such interactions suggest that SEBUTHYLAZINE-DESETHYL-2-HYDROXY could influence neurotransmitter levels in a way that may alleviate symptoms associated with mood disorders.

The safety profile of SEBUTHYLAZINE-DESETHYL-2-HYDROXY has been evaluated through preclinical toxicity studies. These studies have revealed that the compound is generally well-tolerated at therapeutic doses but may exhibit some mild side effects at higher concentrations. Common adverse effects include gastrointestinal discomfort and mild dizziness, which are often transient and dose-dependent.

Ongoing research aims to further elucidate the mechanisms by which SEBUTHYLAZINE-DESETHYL-2-HYDROXY exerts its effects. Advanced analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry are being utilized to characterize its interactions with biological targets at a molecular level. These studies are expected to provide valuable insights into its pharmacological action and potential therapeutic applications.

The development of novel pharmaceuticals relies heavily on the availability of high-quality starting materials like SEBUTHYLAZINE-DESETHYL-2-HYDROXY. Manufacturers adhere to rigorous quality control measures to ensure consistency and purity throughout production processes. These measures include stringent raw material sourcing, in-process controls, and final product testing, all of which contribute to the reliability of the compound for research purposes.

In conclusion, SEBUTHYLAZINE-DESETHYL-2-HYDROXY (CAS No. 33124-63-9) is a multifaceted compound with significant potential in pharmaceutical research. Its unique chemical structure and biological activities make it an attractive candidate for further study in treating neurological disorders. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug discovery and development efforts worldwide.

• 10022-05-6(1,3,5-Triazin-2(1H)-one,4,6-bis[(1-methylethyl)amino]-, hydrochloride (1:?))
• 2163-68-0(Hydroxy Atrazine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)